Key facts
- This page summarizes Robert Dee Etherington's Form 4 filing for Clene Inc. (CLNN).
- 2 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 30 Jul 2024, 09:03.
Robert Dee Etherington - 29 Jul 2024 Form 4 Insider Report for Clene Inc. (CLNN)
- Reporting relationship
- Chief Executive Officer, Director
- Issuer ticker
- CLNN
- Reported as of
- 29 Jul 2024
- Net transaction value
- +$81,960
- SEC form
- 4
- Accepted by SEC
- 30 Jul 2024, 09:03:54 UTC
- Prior SEC filing
- 10 Jun 2024
- Next SEC filing
- 19 Aug 2024
- Source filing
- View source filing
- Reporting owner signature
- /s/ Jerry Miraglia POA
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Robert Dee Etherington filed Form 4 for Clene Inc. (CLNN) on 30 Jul 2024.
Change
- Previous filing in this sequence was filed on 10 Jun 2024.
- Current net transaction value: +$81,960.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
CLNN
transaction
Common Stock
Options Exercise
- Transaction value
- $81,960
- Shares
- +27,320
- Change %
- +966%
- Price
- $3.00*
- Shares after
- 30,149
- Date
- 29 Jul 2024
- Ownership
- Direct
- Footnotes
- F1
CLNN
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 636
- Date
- 29 Jul 2024
- Ownership
- By LLC
- Footnotes
- F2, F3
CLNN
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 1,250
- Date
- 29 Jul 2024
- Ownership
- By trust
- Footnotes
- F4, F5
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
CLNN
transaction
Derivative
Stock Options (Right to buy)
Options Exercise
- Transaction value
- $0
- Shares
- +27,320
- Change %
- Price
- $0.000000
- Shares after
- 27,319
- Date
- 29 Jul 2024
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 27,320
- Exercise price
- $3.00
- Footnotes
- F6
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 6 footnotes
Footnote F1
On July 11, 2024, the common stock of Clene Inc. underwent a 1-for-20 reverse stock split, resulting in the reporting person's ownership in the previously disclosed 56,593 shares of common stock being reduced to 2,829 shares.
Footnote F2
On July 11, 2024, the common stock of Clene Inc. underwent a 1-for-20 reverse stock split, resulting in the reporting person's stock beneficial ownership in the previously disclosed 12,717 shares of common stock indirectly owned being reduced to 636 shares.
Footnote F3
The securities are owned by RDE RX Ventures LLC. Mr. Etherington is the manager of RDE RX Ventures LLC. The shares owned by RDE RX Ventures LLC may also be deemed to be beneficially owned by Mr. Etherington.
Footnote F4
On July 11, 2024, the common stock of Clene Inc. underwent a 1-for-20 reverse stock split, resulting in the reporting person's beneficial ownership in the previously disclosed 25,000 shares of common stock indirectly owned being reduced to 1,250.
Footnote F5
The securities are owned by the Etherington Revocable Trust. Mr. Etherington is the co-trustee of the Etherington Revocable Trust. The shares owned by the Etherington Revocable Trust may be deemed to be beneficially owned by Mr. Etherington.
Footnote F6
On July 11, 2024, the common stock of Clene Inc. underwent a 1-for-20 reverse stock split, resulting in the reporting person's stock option grant of 1,092,777 options to purchase common stock being reduced to 54,639 options. The exercise option price for these options was increased from $0.15 per share to $3.00 per share.